VNRX

Volitionrx Ltd

$0.64

-0 (-0.49%)

Analyst Overview

Target Price:

Date: 07.10.2025

$2.91

(+350.99%)

Strong Buy: 2

Buy: 3

Hold: 1

Sell: 0

Strong Sell: 0

Description:

VolitionRx Limited (VNRX) is a pioneering multinational epigenetics company focused on developing innovative blood-based diagnostic tests for various cancers and other diseases worldwide. Based in Austin, Texas, VolitionRx leverages its proprietary Nu.Q™ platform to create advanced diagnostic solutions that enhance disease detection and patient outcomes. With a commitment to transforming healthcare through early diagnosis, the company is positioned at the forefront of the burgeoning field of epigenetics, catering to a growing demand for non-invasive and accurate diagnostic tools in oncology and beyond.

Exchange:

NYSE MKT

Country:

USA

Sector:

HEALTHCARE

Industry:

MEDICAL DEVICES

Address:

1489 WEST WARM SPRINGS ROAD, HENDERSON, NV, UNITED STATES, 89014

Fiscal year end:

December

Market capitalization:

$69.7 Million

EBITDA:

-$22.4 Million

PERatio:

0.0

EPS:

-0.24

Dividend per share:

$0.00

Dividend yield:

0.0%

Beta:

1.275

Dividends for 10 years

Income Statements for 10 years

Earnings calender

Income count if spend 1000$ ten years ago on shares

How much was you spent on shares:

$1,000

How much will you earn in 10 years:

-85%

How much will you get:

$152

Prices dates:

30-09-2015: $4.48 and 30-09-2025: $0.68